MiR-6875-3p promotes the proliferation, invasion and metastasis of hepatocellular carcinoma via BTG2/FAK/Akt pathway

miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway

(2018) Rongchang Wang et al.   BIOMEDICINE & PHARMACOTHERAPY

CD31 regulates metastasis by inducing epithelial–mesenchymal transition in hepatocellular carcinoma via the ITGB1-FAK-Akt signaling pathway

(2018) Yuan-Yuan Zhang et al.   CANCER LETTERS

A multi-omic study reveals BTG2 as a reliable prognostic marker for early-stage non-small cell lung cancer

(2018) Sipeng Shen et al.   Molecular Oncology

PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma

(2018) Hai Jiang et al.   Cancer Medicine

BTG2 is a tumor suppressor gene upregulated by p53 and PTEN in human bladder carcinoma cells

(2017) Ke-Hung Tsui et al.   Cancer Medicine

MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK/AKT signaling in hepatocellular carcinoma

(2016) Jing-Song Chen et al.   CANCER LETTERS

Novel combination of serum microRNA for detecting breast cancer in the early stage

(2016) Akihiko Shimomura et al.   CANCER SCIENCE

MicroRNA-6826 and −6875 in plasma are valuable non-invasive biomarkers that predict the efficacy of vaccine treatment against metastatic colorectal cancer

(2016) Taiki Kijima et al.   ONCOLOGY REPORTS

Inhibition of breast cancer invasion by TIS21/BTG2/Pc3-Akt1-Sp1-Nox4 pathway targeting actin nucleators, mDia genes

(2015) J-A Choi et al.   ONCOGENE

Tumor-associated macrophages promote cancer stem cell-like properties via transforming growth factor-beta1-induced epithelial–mesenchymal transition in hepatocellular carcinoma

(2014) Qing-Min Fan et al.   CANCER LETTERS

BTG2: A rising star of tumor suppressors (Review)

(2014) BIJING MAO et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Molecular Biology of Liver Cancer Stem Cells

(2014) Naoki Oishi et al.   Liver Cancer

Endogenous BTG2 expression stimulates migration of bladder cancer cells and correlates with poor clinical prognosis for bladder cancer patients

(2013) N Wagener et al.   BRITISH JOURNAL OF CANCER

Relevant markers of cancer stem cells indicate a poor prognosis in hepatocellular carcinoma patients

(2013) Yu-Cheng Ma et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

BTG2 inhibits the proliferation, invasion, and apoptosis of MDA-MB-231 triple-negative breast cancer cells

(2013) Yan-jun Zhang et al.   TUMOR BIOLOGY

BTG2 suppresses cancer cell migration through inhibition of Src-FAK signaling by downregulation of reactive oxygen species generation in mitochondria

(2012) Seo-Kyung Lim et al.   CLINICAL & EXPERIMENTAL METASTASIS

BTG2 loss and miR-21 upregulation contribute to prostate cell transformation by inducing luminal markers expression and epithelial–mesenchymal transition

(2012) V Coppola et al.   ONCOGENE

Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB/HER inhibitor lapatinib

(2011) F Takahashi et al.   ONCOGENE

The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells

(2008) Sendurai A. Mani et al.   CELL